Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

Translational psychiatry - 3 Jul 2012

Adkins D E, Clark S L, Åberg K, Hettema J M, Bukszár J, McClay J L, Souza R P, van den Oord E J C G

Abstract excerpt

Affecting about 1 in 12 Americans annually, depression is a leading cause of the global disease burden. While a range of effective antidepressants are now available, failure and relapse rates remain substantial, with intolerable side effect burden the most commonly cited reason for discontinuation. Thus, understanding individual differences in susceptibility to antidepressant therapy side effects will be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Citalopram

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Factor Analysis, Statistical

Share to Genetic Variation

Share to Genome-Wide Association Study

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 22760553
DOI: 10.1038/tp.2012.57
PMCID: PMC3410623

Genes

EGFLAM
FHIT
LAMA1
RTP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.PMID 22760553Read ↗

Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.Semantic proximity Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

Genome-wide association studies of antidepressant outcome: a brief review.Semantic proximity Read ↗

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.Semantic proximity Read ↗

Genetic Inference of On-target and Off-target Side-effects of Antipsychotic MedicationsSemantic proximity Read ↗

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.Semantic proximity Read ↗

Identifying genetic variants associated with side effects of antidepressant treatment: A systematic review.Semantic proximity Read ↗

A genomewide association study of citalopram response in major depressive disorder.Semantic proximity Read ↗

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.Semantic proximity Read ↗

Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion responseSemantic proximity Read ↗

Genomic predictors of response to antidepressants in Major depressive disorder (MDD): A GWAS-Based Study on Indian cohortSemantic proximity Read ↗

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.